Erratum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion (Nature (2015) 517 (386-390) DOI: 10.1038/nature13848);CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

Nature

Volumn 517, Issue 7534, 2015, Pages 386-390

  Huang, Yu Hwa ^a   Zhu, Chen ^b   Kondo, Yasuyuki ^a   Anderson, Ana C ^b   Gandhi, Amit ^a   Russell, Andrew ^c   Dougan, Stephanie K ^d   Petersen, Britt Sabina ^e   Melum, Espen ^a,f   Pertel, Thomas ^b   Clayton, Kiera L ^g   Raab, Monika ^h   Chen, Qiang ⁱ   Beauchemin, Nicole ^j   Yazaki, Paul J ^k   Pyzik, Michal ^a   Ostrowski, Mario A ^g,l   Glickman, Jonathan N ^m   Rudd, Christopher E ^h   Ploegh, Hidde L ^d   Franke, Andre ^e   Petsko, Gregory A ^c   Kuchroo, Vijay K ^b   Blumberg, Richard S ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BRANDEIS UNIVERSITY   (United States)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITY OF KIEL   (Germany)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ SICHUAN UNIVERSITY   (China)

^j MCGILL UNIVERSITY   (Canada)

^k CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^l ST MICHAEL'S HOSPITAL   (Canada)

^m MIRACA LIFE SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CELL PROTEIN; CYTOKINE; T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 3; UNCLASSIFIED DRUG; CD66 ANTIGENS; CELL ADHESION MOLECULE; HAVCR2 PROTEIN, HUMAN; HAVCR2 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN; VIRUS RECEPTOR;

GENE EXPRESSION; HORMONE; IMMUNITY; INHIBITOR; RODENT; TOLERANCE; TUMOR; VIRAL DISEASE;

ADOPTIVE TRANSFER; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CELL SPECIFICITY; CELL SURFACE; COLITIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; X RAY CRYSTALLOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; COLORECTAL TUMOR; DISEASE MODEL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MUCOSA; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; AUTOIMMUNITY; CELL ADHESION MOLECULES; CELL LINE; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; LIGANDS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, MOLECULAR; MUCOUS MEMBRANE; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECEPTORS, VIRUS; T-LYMPHOCYTES;

EID: 84921449533     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature17421     Document Type: Erratum

References (56)

1. Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536-541 (2002).
2. Sabatos, C. A. et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nature Immunol. 4, 1102-1110 (2003).
3. Sánchez-Fueyo, A. et al. Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immunological tolerance. Nature Immunol. 4, 1093-1101 (2003).
4. Jones, R. B. et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205, 2763-2779 (2008).
5. Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187-2194 (2010).
6. Nagaishi, T. et al. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25, 769-781 (2006).
7. Gray-Owen, S. D. & Blumberg, R. S. CEACAM1: contact-dependent control of immunity. Nature Rev. Immunol. 6, 433-446 (2006).
8. Iijima, H. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199, 471-482 (2004).
9. Boulton, I. C. & Gray-Owen, S. D. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD41 T lymphocytes. Nature Immunol. 3, 229-236 (2002).
10. Chen, L. et al. The short isoform of the CEACAM1 receptor in intestinal t cells regulatesmucosal immunity and homeostasis via Tfh cell induction. Immunity 37, 930-946 (2012).
11. Kearney, E. R., Pape, K. A., Joh, D. Y.Jenkins, M. K. Visualizationof peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994).
12. Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nature Methods 3, 995-1000 (2006).
13. Cao, E. et al. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 26, 311-321 (2007).
14. Tan, K. et al. Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J. 21, 2076-2086 (2002).
15. Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nature Immunol. 6, 1245-1252 (2005).
16. Dardalhon, V. et al. Tim-3/galectin-9pathway: regulationofTh1immunity through promotion of CD11b1Ly-6G1 myeloid cells. J. Immunol. 185, 1383-1392 (2010).
17. Rangachari, M. et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nature Med. 18, 1394-1400 (2012).
18. Lee, J. et al. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 31, 3963-3974 (2011).
19. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature Cell Biol. 439, 682-687 (2006).
20. Hirahara, K. et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36, 1017-1030 (2012).
21. Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007).
22. Fridman, W. H., Pagès, F., Sautès-Fridman, C.Galon, J. Theimmune contexture in human tumours: impact on clinical outcome. Nature Rev. Cancer 12, 298-306 (2012).
23. Huang, A. Y. et al. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl Acad. Sci. USA 93, 9730-9735 (1996).
24. Leung, N. et al. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 25, 5527-5536 (2006).
25. Bansal-Pakala, P., Jember, A. G. & Croft, M. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nature Med. 7, 907-912 (2001).
26. Jeon, M.-S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167-177 (2004).
27. Moon, J. J. et al. Tracking epitope-specific T cells. Nature Protocols 4, 565-581 (2009).
28. Chen, C.-J. & Shively, J. E. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with Src homology protein-1 and down-regulates IL-2 receptor. J. Immunol. 172, 3544-3552 (2004).
29. Patel, P. C. et al. Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties. J. Biol. Chem. 288, 29654-29669 (2013).
30. Smith, A. L. et al. Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo. J. Infect. Dis. 163, 879-882 (1991).
31. Gallagher, T. M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71, 3129-3137 (1997).
32. Morales, V. M. et al. Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 163, 1363-1370 (1999).
33. Watt, S. M. Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood 98, 1469-1479 (2001).
34. Chen, D. et al. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function. J. Immunol. 172, 3535-3543 (2004).
35. Hastings, W. D. et al. TIM-3 is expressed on activated human CD41 T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 39, 2492-2501 (2009).
36. Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365 (2011).
37. Holst, J., Vignali, K. M., Burton, A. R. & Vignali, D. A. A. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nature Methods 3, 191-197 (2006).
38. Persons, D. A. et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777-1786 (1997).
39. Zhang, X., Schwartz, J.-C. D., Almo, S. C. & Nathenson, S. G. Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2. Protein Expr. Purif. 25, 105-113 (2002).
40. Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. W. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D 67, 271-281 (2011).
41. Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D 67, 235-242 (2011).
42. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213-221 (2010).
43. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
44. Mizuguchi, K.& Go, N. Seeking significance in three-dimensional protein structure comparisons. Curr. Opin. Struct. Biol. 5, 377-382 (1995).
45. Thompson, J. D., Gibson, T. J. & Higgins, D. G. Multiple sequence alignment using ClustalW and ClustalX. Curr. Protoc. Bioinformatics Chapter 2, Unit 2.3 (2002).
46. Lyskov, S. & Gray, J. J. The RosettaDock server for local protein-protein docking. Nucleic Acids Res. 36, W233-W238 (2008).
47. Kaufmann, K. W., Lemmon, G. H.,DeLuca,S. L.,Sheehan, J. H. Meiler, J. Practically useful: what the ROSETTA protein modeling suite can do for you. Biochemistry 49, 2987-2998 (2010).
48. Lennard-Jones, J. E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 170, 2-6 (1989).
49. Truelove, S. C. & Pena, A. S. Course and prognosis of Crohn's disease. Gut 17, 192-201 (1976).
50. Krawczak, M. et al.PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 9, 55-61 (2006).
51. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
52. Ye, K. et al. Phospholipase Cc1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature 415, 541-544 (2002).
53. Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. & Coffman, R. L. Phenotypically distinct subsets of CD41 T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461-1471 (1993).
54. Okayasu, I., Ohkusa, T., Kajiura, K., Kanno, J. Sakamoto, S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 39, 87-92 (1996).
55. Neufert, C., Becker, C. & Neurath, M. F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nature Protocols 2, 1998-2004 (2007).
56. Adolph, T. E. et al. Paneth cells as a site of origin for intestinal inflammation. Nature 503, 272-276 (2013).